New SCPC Comments to FTC Detail Steps to Foster Competition in Pharmaceutical Pricing and Supply Chain

2017 Year-End Focus on Drug Pricing by Senate HELP, House Energy and Commerce Committees Demonstrate Ongoing Saliency of Examining PBM Market Manipulation

WASHINGTONDec. 12, 2017 /PRNewswire-USNewswire/ — In the wake of issuing new comments to the Federal Trade Commission (FTC) detailing steps to foster more competition in the prescription drug marketplace, the Senior Care Pharmacy Coalition (SCPC) welcomed both House and Senate year-end hearings on drug pricing and associated supply chain issues to reform an opaque pharmacy benefit manager (PBM) business model that keeps consumers, lawmakers and regulators alike in the dark about pricing determinations and activities and that adds costs to consumers while reducing their access to clinically appropriate medications.

Read more here…

NEWS PROVIDED BY

Senior Care Pharmacy Coalition 

Dec 12, 2017, 10:35 ET